Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England.

Gema Requena Alexandrosz Czira Victoria L Banks Robert P WoodTheo TrittonCatherine M CastilloJie YeapRosie A C Wild Chris Compton Kieran J Rothnie Felix J F Herth Jennifer Kathleen Quint Afisi S Ismaila

Published in: International journal of chronic obstructive pulmonary disease (2023)

UMEC/VI was superior to TIO/OLO in reducing rescue medication prescriptions at 12 months after treatment initiation in a primary care cohort in England, potentially suggesting improvements in symptom control with UMEC/VI compared with TIO/OLO.

Keyphrases

clinical practice
primary care
quantum dots
adverse drug
healthcare
visible light
emergency department
patient reported